| 1N1M | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR |
| 1NU8 | B:108-479; B:108-479 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV) IN COMPLEX WITH DIPROTIN A (IPI) |
| 1PFQ | B:108-479; B:108-479 | CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV / CD26 |
| 1R9M | D:108-479; D:108-479; D:108-479; D:108-479 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV AT 2.1 ANG. RESOLUTION. |
| 1R9N | D:108-479; D:108-479; D:108-479; D:108-479 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A DECAPEPTIDE (TNPY) AT 2.3 ANG. RESOLUTION |
| 1RWQ | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 5-AMINOMETHYL-6-(2,4-DICHLORO-PHENYL)-2-(3,5-DIMETHOXY-PHENYL)-PYRIMIDIN-4-YLAMINE |
| 1TK3 | B:108-479; B:108-479 | CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/CD26 |
| 1TKR | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITH DIISOPROPYL FLUOROPHOSPHATE |
| 1U8E | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F |
| 1W1I | D:108-479; D:108-479; D:108-479; D:108-479 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE |
| 1WCY | B:108-479; B:108-479 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH DIPROTIN A |
| 1X70 | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR |
| 2JID | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 1-(3,4-DIMETHOXY-PHENYL)-3-M-TOLYL-PIPERIDINE-4-YLAMINE |
| 2OAG | D:108-479; D:108-479; D:108-479; D:108-479 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) WITH PYRROLIDINE-CONSTRAINED PHENETHYLAMINE 29G |
| 2OGZ | B:108-479; B:108-479 | CRYSTAL STRUCTURE OF DPP-IV COMPLEXED WITH LILLY ARYL KETONE INHIBITOR |
| 2ONC | D:108-479; D:108-479; D:108-479; D:108-479 | CRYSTAL STRUCTURE OF HUMAN DPP-4 |
| 2OPH | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH AN ALPHA AMINO ACID INHIBITOR |
| 2OQI | D:108-479; D:108-479; D:108-479; D:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV (DPP4) WITH PIPERIDINONE-CONSTRAINED PHENETHYLAMINE |
| 2OQV | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV (DPP4) WITH PIPERIDINE-CONSTRAINED PHENETHYLAMINE |
| 2QKY | D:108-479; D:108-479; D:108-479; D:108-479 | COMPLEX STRUCTURE OF DIPEPTIDYL PEPTIDASE IV AND A OXADIAZOLYL KETONE |
| 2QOE | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A TRIAZOLOPIPERAZINE-BASED BETA AMINO ACID INHIBITOR |
| 2QT9 | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A 4-ARYL CYCLOHEXYLALANINE INHIBITOR |
| 2QTB | B:108-479; B:108-479 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A 4-ARYL CYCLOHEXYLALANINE INHIBITOR |
| 2RGU | B:108-479; B:108-479 | CRYSTAL STRUCTURE OF COMPLEX OF HUMAN DPP4 AND INHIBITOR |
| 2RIP | A:108-479 | STRUCTURE OF DPPIV IN COMPLEX WITH AN INHIBITOR |
| 3KWF | B:108-479; B:108-479 | HUMAN DPP-IV WITH CARMEGLIPTIN (S)-1-((2S,3S,11BS)-2-AMINO-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-3-YL)-4-FLUOROMETHYL-PYRROLIDIN-2-ONE |
| 3KWJ | B:108-479; B:108-479 | STRUCUTRE OF HUMAN DPP-IV WITH (2S,3S,11BS)-3-(3-FLUOROMETHYL-PHENYL)-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-2-YLAMINE |
| 3O95 | D:108-479; D:108-479; D:108-479; D:108-479 | CRYSTAL STRUCTURE OF HUMAN DPP4 BOUND TO TAK-100 |
| 3O9V | D:108-479; D:108-479; D:108-479; D:108-479 | CRYSTAL STRUCTURE OF HUMAN DPP4 BOUND TO TAK-986 |
| 3OC0 | B:108-479; B:108-479 | STRUCTURE OF HUMAN DPP-IV WITH HTS HIT (2S,3S,11BS)-3-BUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-2-YLAMINE |
| 3Q8W | B:108-479; B:108-479 | A B-AMINOACYL CONTAINING THIAZOLIDINE DERIVATIVE AND DPPIV COMPLEX |
| 1XFD | D:195-561; D:195-561; D:195-561; D:195-561 | STRUCTURE OF A HUMAN A-TYPE POTASSIUM CHANNEL ACCELERATING FACTOR DPPX, A MEMBER OF THE DIPEPTIDYL AMINOPEPTIDASE FAMILY |
| 1Z68 | B:106-473; B:106-473 | CRYSTAL STRUCTURE OF HUMAN FIBROBLAST ACTIVATION PROTEIN ALPHA |
)
)